Education
About Us
Working with TipRanks
Follow Us
Alphatec Holdings (ATEC)
NASDAQ:ATEC
ATEC Stock Chart & Stats
$19.61
$0.31(3.32%)
At close: 4:00 PM EST
$19.61
$0.31(3.32%)
Day’s Range― - ―
52-Week Range$8.70 - $21.16
Previous CloseN/A
Volume519.80K
Average Volume (3M)2.66M
Market Cap
$2.91B
Enterprise Value$2.66B
Total Cash (Recent Filing)$155.74M
Total Debt (Recent Filing)$591.15M
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Mar 03, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding148,550,190
10 Day Avg. Volume2,364,604
30 Day Avg. Volume2,664,693
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)139.10
Price to Sales (P/S)2.15
P/FCF Ratio-9.52
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue3.65
Enterprise Value/Gross Profit5.28
Enterprise Value/Ebitda-50.95
Forecast
1Y Price Target
$22.82Price Target Upside16.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.01
Revenue Forecast (FY)$758.74M
Bulls Say, Bears Say
Bulls Say
EarningsATEC had a strong quarter, with 30% top-line growth that once again marked an industry-leading result.
GuidanceATEC raised its full-year guidance for both sales and EBITDA.
Product Launches2026 is catalyst-rich, with several product launches ahead including lateral, deformity, and VALENCE as three key opportunities.
Bears Say
Alphatec Holdings News
ATEC FAQ
What was Alphatec Holdings’s price range in the past 12 months?
Alphatec Holdings lowest stock price was $8.70 and its highest was $21.16 in the past 12 months.
What is Alphatec Holdings’s market cap?
Alphatec Holdings’s market cap is $2.91B.
When is Alphatec Holdings’s upcoming earnings report date?
Alphatec Holdings’s upcoming earnings report date is Mar 03, 2026 which is in 101 days.
How were Alphatec Holdings’s earnings last quarter?
Alphatec Holdings released its earnings results on Oct 30, 2025. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$0.031 by $0.061.
Is Alphatec Holdings overvalued?
According to Wall Street analysts Alphatec Holdings’s price is currently Undervalued.
Does Alphatec Holdings pay dividends?
Alphatec Holdings does not currently pay dividends.
What is Alphatec Holdings’s EPS estimate?
Alphatec Holdings’s EPS estimate is 0.05.
How many shares outstanding does Alphatec Holdings have?
Alphatec Holdings has 148,550,190 shares outstanding.
What happened to Alphatec Holdings’s price movement after its last earnings report?
Alphatec Holdings reported an EPS of $0.03 in its last earnings report, beating expectations of -$0.031. Following the earnings report the stock price went up 16.289%.
Which hedge fund is a major shareholder of Alphatec Holdings?
Currently, no hedge funds are holding shares in ATEC
Alphatec Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.82 (16.37% Upside)
$22.82 (16.37% Upside)
Blogger Sentiment
Neutral
ATEC Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 98.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $25.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
105.01%
12-Months-Change
Fundamentals
Return on Equity
-540.40%
Trailing 12-Months
Asset Growth
5.54%
Trailing 12-Months
Company Description
Alphatec Holdings
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
ATEC Company Deck
ATEC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
ATEC demonstrated strong financial performance with significant revenue growth, increased surgeon adoption, and positive free cash flow. The company raised its full-year guidance and achieved record adjusted EBITDA. While there are some challenges related to tariff impacts and market disruption, the overall performance and strategic positioning indicate a positive outlook.View all ATEC earnings summariesATEC Stock 12 Month Forecast
Average Price Target
$22.82
▲(16.37% Upside)
Technical Analysis
Ownership Overview
41.52% Insiders
14.42% Mutual Funds
16.52% Other Institutional Investors
14.73% Public Companies and
Individual Investors